_id
6919f0f53c536f8df23185c1
Ticker
0QF.XETRA
Name
Moderna, Inc.
Exchange
XETRA
Address
325 Binney Street, Cambridge, MA, United States, 02142
Country
Germany
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.modernatx.com
Description
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Last Close
26.325
Volume
2920
Current Price
27.47
Change
0.7407407407407418
Last Updated
2025-12-30T11:49:09.871Z
Image
https://logo.clearbit.com/www.modernatx.com
Ipo Date
-
Market Cap
10574773248
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-03-31
Revenue
167000000
Cost Of Revenue
96000000
Gross Profit
71000000
Operating Expenses
1433000000
Operating Income
-1266000000
Interest Expense
6000000
Pretax Income
-1165000000
Net Income
-1175000000
Eps
-3.0678851174934727
Dividends Per Share
-
Shares Outstanding
390733636
Income Tax Expense
-
EBITDA
-
Operating Margin
-758.0838323353294
Total Other Income Expense Net
-13000000
Cash
2051000000
Short Term Investments
6472000000
Receivables
137000000
Inventories
295000000
Total Current Assets
9600000000
Property Plant Equipment
2760000000
Total Assets
16729000000
Payables
183000000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
3912000000
Equity
12817000000
Bs_currency_symbol
USD
Depreciation
36000000
Change In Working Capital
60000000
Cash From Operations
-989000000
Capital Expenditures
196000000
Cash From Investing
-
Cash From Financing
14000000
Net Change In Cash
-857000000
Cf_currency_symbol
USD
PE
-
PB
0.8208636966528827
ROE
-9.167511898260123
ROA
-7.023731245143165
FCF
-1185000000
Fcf Percent
-7.095808383233533
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1.5
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
7
Quarters > 0 > quarter
2024-03-31
Quarters > 0 > income Statement > revenue
167000000
Quarters > 0 > income Statement > cost Of Revenue
96000000
Quarters > 0 > income Statement > gross Profit
71000000
Quarters > 0 > income Statement > operating Expenses
1433000000
Quarters > 0 > income Statement > operating Income
-1266000000
Quarters > 0 > income Statement > interest Expense
6000000
Quarters > 0 > income Statement > pretax Income
-1165000000
Quarters > 0 > income Statement > net Income
-1175000000
Quarters > 0 > income Statement > eps
-3.0678851174934727
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
383000000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-758.0838323353294
Quarters > 0 > income Statement > total Other Income Expense Net
-13000000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2051000000
Quarters > 0 > balance Sheet > short Term Investments
6472000000
Quarters > 0 > balance Sheet > receivables
137000000
Quarters > 0 > balance Sheet > inventories
295000000
Quarters > 0 > balance Sheet > total Current Assets
9600000000
Quarters > 0 > balance Sheet > property Plant Equipment
2760000000
Quarters > 0 > balance Sheet > total Assets
16729000000
Quarters > 0 > balance Sheet > payables
183000000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3912000000
Quarters > 0 > balance Sheet > equity
12817000000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1175000000
Quarters > 0 > cash Flow > depreciation
36000000
Quarters > 0 > cash Flow > change In Working Capital
60000000
Quarters > 0 > cash Flow > cash From Operations
-989000000
Quarters > 0 > cash Flow > capital Expenditures
196000000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
14000000
Quarters > 0 > cash Flow > net Change In Cash
-857000000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-3.0678851174934727
Quarters > 0 > ratios > PB
0.8208636966528827
Quarters > 0 > ratios > ROE
-9.167511898260123
Quarters > 0 > ratios > ROA
-7.023731245143165
Quarters > 0 > ratios > FCF
-1185000000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-7.095808383233533
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2023-12-31
Quarters > 1 > income Statement > revenue
2813000000
Quarters > 1 > income Statement > cost Of Revenue
929000000
Quarters > 1 > income Statement > gross Profit
1884000000
Quarters > 1 > income Statement > operating Expenses
2807000000
Quarters > 1 > income Statement > operating Income
6000000
Quarters > 1 > income Statement > interest Expense
6000000
Quarters > 1 > income Statement > pretax Income
70000000
Quarters > 1 > income Statement > net Income
217000000
Quarters > 1 > income Statement > eps
0.5680628272251309
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
382000000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
0.21329541414859582
Quarters > 1 > income Statement > total Other Income Expense Net
-33000000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2907000000
Quarters > 1 > balance Sheet > short Term Investments
5697000000
Quarters > 1 > balance Sheet > receivables
892000000
Quarters > 1 > balance Sheet > inventories
202000000
Quarters > 1 > balance Sheet > total Current Assets
10325000000
Quarters > 1 > balance Sheet > property Plant Equipment
2658000000
Quarters > 1 > balance Sheet > total Assets
18426000000
Quarters > 1 > balance Sheet > payables
520000000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4572000000
Quarters > 1 > balance Sheet > equity
13854000000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
217000000
Quarters > 1 > cash Flow > depreciation
202000000
Quarters > 1 > cash Flow > change In Working Capital
249000000
Quarters > 1 > cash Flow > cash From Operations
622000000
Quarters > 1 > cash Flow > capital Expenditures
220000000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-109000000
Quarters > 1 > cash Flow > net Change In Cash
-25000000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
0.5680628272251309
Quarters > 1 > ratios > PB
0.7574375631586545
Quarters > 1 > ratios > ROE
1.566334632597084
Quarters > 1 > ratios > ROA
1.1776837078041897
Quarters > 1 > ratios > FCF
402000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.1429079274795592
Quarters > 1 > health Score
65
Quarters > 2 > quarter
2023-09-30
Quarters > 2 > income Statement > revenue
1787000000
Quarters > 2 > income Statement > cost Of Revenue
2241000000
Quarters > 2 > income Statement > gross Profit
-454000000
Quarters > 2 > income Statement > operating Expenses
3799000000
Quarters > 2 > income Statement > operating Income
-2012000000
Quarters > 2 > income Statement > interest Expense
10000000
Quarters > 2 > income Statement > pretax Income
-1958000000
Quarters > 2 > income Statement > net Income
-3630000000
Quarters > 2 > income Statement > eps
-9.527559055118111
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
381000000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-112.59093452714046
Quarters > 2 > income Statement > total Other Income Expense Net
-41000000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2932000000
Quarters > 2 > balance Sheet > short Term Investments
4641000000
Quarters > 2 > balance Sheet > receivables
1866000000
Quarters > 2 > balance Sheet > inventories
487000000
Quarters > 2 > balance Sheet > total Current Assets
10799000000
Quarters > 2 > balance Sheet > property Plant Equipment
2717000000
Quarters > 2 > balance Sheet > total Assets
19450000000
Quarters > 2 > balance Sheet > payables
494000000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5995000000
Quarters > 2 > balance Sheet > equity
13455000000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3630000000
Quarters > 2 > cash Flow > depreciation
249000000
Quarters > 2 > cash Flow > change In Working Capital
182000000
Quarters > 2 > cash Flow > cash From Operations
-1600000000
Quarters > 2 > cash Flow > capital Expenditures
140000000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-58000000
Quarters > 2 > cash Flow > net Change In Cash
-869000000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-9.527559055118111
Quarters > 2 > ratios > PB
0.7778573021181716
Quarters > 2 > ratios > ROE
-26.978818283166113
Quarters > 2 > ratios > ROA
-18.663239074550127
Quarters > 2 > ratios > FCF
-1740000000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.9736989367655288
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
316000000
Quarters > 3 > income Statement > cost Of Revenue
731000000
Quarters > 3 > income Statement > gross Profit
-415000000
Quarters > 3 > income Statement > operating Expenses
2183000000
Quarters > 3 > income Statement > operating Income
-1867000000
Quarters > 3 > income Statement > interest Expense
13000000
Quarters > 3 > income Statement > pretax Income
-1749000000
Quarters > 3 > income Statement > net Income
-1380000000
Quarters > 3 > income Statement > eps
-3.622047244094488
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
381000000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-590.8227848101266
Quarters > 3 > income Statement > total Other Income Expense Net
27000000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3801000000
Quarters > 3 > balance Sheet > short Term Investments
4658000000
Quarters > 3 > balance Sheet > receivables
232000000
Quarters > 3 > balance Sheet > inventories
715000000
Quarters > 3 > balance Sheet > total Current Assets
10599000000
Quarters > 3 > balance Sheet > property Plant Equipment
2410000000
Quarters > 3 > balance Sheet > total Assets
21884000000
Quarters > 3 > balance Sheet > payables
310000000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4935000000
Quarters > 3 > balance Sheet > equity
16949000000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1380000000
Quarters > 3 > cash Flow > depreciation
92000000
Quarters > 3 > cash Flow > change In Working Capital
574000000
Quarters > 3 > cash Flow > cash From Operations
-915000000
Quarters > 3 > cash Flow > capital Expenditures
234000000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-668000000
Quarters > 3 > cash Flow > net Change In Cash
361000000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-3.622047244094488
Quarters > 3 > ratios > PB
0.6175036875331877
Quarters > 3 > ratios > ROE
-8.142073278659508
Quarters > 3 > ratios > ROA
-6.305976969475416
Quarters > 3 > ratios > FCF
-1149000000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-3.6360759493670884
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
6754000000
Annuals > 0 > income Statement > cost Of Revenue
4693000000
Annuals > 0 > income Statement > gross Profit
2061000000
Annuals > 0 > income Statement > operating Expenses
10993000000
Annuals > 0 > income Statement > operating Income
-4239000000
Annuals > 0 > income Statement > interest Expense
38000000
Annuals > 0 > income Statement > pretax Income
-3942000000
Annuals > 0 > income Statement > net Income
-4714000000
Annuals > 0 > income Statement > eps
-12.340314136125654
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
382000000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-62.76280722534794
Annuals > 0 > income Statement > total Other Income Expense Net
-86000000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2907000000
Annuals > 0 > balance Sheet > short Term Investments
5697000000
Annuals > 0 > balance Sheet > receivables
892000000
Annuals > 0 > balance Sheet > inventories
202000000
Annuals > 0 > balance Sheet > total Current Assets
10325000000
Annuals > 0 > balance Sheet > property Plant Equipment
2658000000
Annuals > 0 > balance Sheet > total Assets
18426000000
Annuals > 0 > balance Sheet > payables
520000000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4572000000
Annuals > 0 > balance Sheet > equity
13854000000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-4714000000
Annuals > 0 > cash Flow > depreciation
621000000
Annuals > 0 > cash Flow > change In Working Capital
-139000000
Annuals > 0 > cash Flow > cash From Operations
-3118000000
Annuals > 0 > cash Flow > capital Expenditures
707000000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-1377000000
Annuals > 0 > cash Flow > net Change In Cash
-289000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-12.340314136125654
Annuals > 0 > ratios > PB
0.7266933737548722
Annuals > 0 > ratios > ROE
-34.02627400028872
Annuals > 0 > ratios > ROA
-25.583414740041242
Annuals > 0 > ratios > FCF
-3825000000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.566331063073734
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
18875000000
Annuals > 1 > income Statement > cost Of Revenue
5416000000
Annuals > 1 > income Statement > gross Profit
13459000000
Annuals > 1 > income Statement > operating Expenses
9455000000
Annuals > 1 > income Statement > operating Income
9420000000
Annuals > 1 > income Statement > interest Expense
29000000
Annuals > 1 > income Statement > pretax Income
9575000000
Annuals > 1 > income Statement > net Income
8362000000
Annuals > 1 > income Statement > eps
21.71948051948052
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
385000000
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
49.907284768211916
Annuals > 1 > income Statement > total Other Income Expense Net
-16000000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3205000000
Annuals > 1 > balance Sheet > short Term Investments
6697000000
Annuals > 1 > balance Sheet > receivables
1385000000
Annuals > 1 > balance Sheet > inventories
949000000
Annuals > 1 > balance Sheet > total Current Assets
13431000000
Annuals > 1 > balance Sheet > property Plant Equipment
2139000000
Annuals > 1 > balance Sheet > total Assets
25858000000
Annuals > 1 > balance Sheet > payables
487000000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6735000000
Annuals > 1 > balance Sheet > equity
19123000000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
8362000000
Annuals > 1 > cash Flow > depreciation
348000000
Annuals > 1 > cash Flow > change In Working Capital
-3455000000
Annuals > 1 > cash Flow > cash From Operations
4981000000
Annuals > 1 > cash Flow > capital Expenditures
400000000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-3448000000
Annuals > 1 > cash Flow > net Change In Cash
-3643000000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
21.71948051948052
Annuals > 1 > ratios > PB
0.5306005856821628
Annuals > 1 > ratios > ROE
43.72744862207812
Annuals > 1 > ratios > ROA
32.33815453631371
Annuals > 1 > ratios > FCF
4581000000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.24270198675496688
Annuals > 1 > health Score
89
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
17736000000
Annuals > 2 > income Statement > cost Of Revenue
2617000000
Annuals > 2 > income Statement > gross Profit
15119000000
Annuals > 2 > income Statement > operating Expenses
4440000000
Annuals > 2 > income Statement > operating Income
13296000000
Annuals > 2 > income Statement > interest Expense
18000000
Annuals > 2 > income Statement > pretax Income
13285000000
Annuals > 2 > income Statement > net Income
12202000000
Annuals > 2 > income Statement > eps
30.277915632754343
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
403000000
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
74.96617050067658
Annuals > 2 > income Statement > total Other Income Expense Net
-29000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
6848000000
Annuals > 2 > balance Sheet > short Term Investments
3879000000
Annuals > 2 > balance Sheet > receivables
3175000000
Annuals > 2 > balance Sheet > inventories
1441000000
Annuals > 2 > balance Sheet > total Current Assets
16071000000
Annuals > 2 > balance Sheet > property Plant Equipment
1383000000
Annuals > 2 > balance Sheet > total Assets
24669000000
Annuals > 2 > balance Sheet > payables
302000000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
10524000000
Annuals > 2 > balance Sheet > equity
14145000000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
12202000000
Annuals > 2 > cash Flow > depreciation
232000000
Annuals > 2 > cash Flow > change In Working Capital
1308000000
Annuals > 2 > cash Flow > cash From Operations
13620000000
Annuals > 2 > cash Flow > capital Expenditures
284000000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-873000000
Annuals > 2 > cash Flow > net Change In Cash
4224000000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
30.277915632754343
Annuals > 2 > ratios > PB
0.7508706256627784
Annuals > 2 > ratios > ROE
86.2636974195829
Annuals > 2 > ratios > ROA
49.46288864566865
Annuals > 2 > ratios > FCF
13336000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.7519170049616599
Annuals > 2 > health Score
82
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
274000000
Annuals > 3 > income Statement > cost Of Revenue
8000000
Annuals > 3 > income Statement > gross Profit
266000000
Annuals > 3 > income Statement > operating Expenses
1037000000
Annuals > 3 > income Statement > operating Income
-763000000
Annuals > 3 > income Statement > interest Expense
9886000
Annuals > 3 > income Statement > pretax Income
-744000000
Annuals > 3 > income Statement > net Income
-747000000
Annuals > 3 > income Statement > eps
-1.8731772349295106
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
398787678
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-278.46715328467155
Annuals > 3 > income Statement > total Other Income Expense Net
-6000000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2624000000
Annuals > 3 > balance Sheet > short Term Investments
1984000000
Annuals > 3 > balance Sheet > receivables
1391000000
Annuals > 3 > balance Sheet > inventories
47000000
Annuals > 3 > balance Sheet > total Current Assets
6298000000
Annuals > 3 > balance Sheet > property Plant Equipment
387000000
Annuals > 3 > balance Sheet > total Assets
7337000000
Annuals > 3 > balance Sheet > payables
18000000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4776000000
Annuals > 3 > balance Sheet > equity
2561000000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-747064000
Annuals > 3 > cash Flow > depreciation
31000000
Annuals > 3 > cash Flow > change In Working Capital
2578000000
Annuals > 3 > cash Flow > cash From Operations
2027000000
Annuals > 3 > cash Flow > capital Expenditures
68000000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
2033000000
Annuals > 3 > cash Flow > net Change In Cash
2388000000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-1.8731772349295106
Annuals > 3 > ratios > PB
4.103884909679812
Annuals > 3 > ratios > ROE
-29.16829363529871
Annuals > 3 > ratios > ROA
-10.181272999863705
Annuals > 3 > ratios > FCF
1959000000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
7.149635036496351
Annuals > 3 > health Score
39
Valuation > metrics > PE
-3.0678851174934727
Valuation > metrics > PB
0.8208636966528827
Valuation > final Score
70
Valuation > verdict
17.9% Undervalued
Profitability > metrics > ROE
-9.167511898260123
Profitability > metrics > ROA
-12.239583333333332
Profitability > metrics > Net Margin
-7.0359281437125745
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.30521963017866893
Risk > metrics > Interest Coverage
-211
Risk > final Score
-784
Risk > verdict
High
Liquidity > metrics > Current Ratio
52.459016393442624
Liquidity > metrics > Quick Ratio
50.84699453551912
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
21
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
64
Prev Risks > 1
-745
Prev Risks > 2
-514
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:05:09.772Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-29
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-12
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-2.76
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-11-06
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.4389
Earnings History > 2 > eps Estimate
-2.19
Earnings History > 2 > eps Difference
1.7511
Earnings History > 2 > surprise Percent
79.9589
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-08-01
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.8745
Earnings History > 3 > eps Estimate
-3.01
Earnings History > 3 > eps Difference
1.1355
Earnings History > 3 > surprise Percent
37.7243
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-05-01
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-2.3901
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-02-20
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-2.7272
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-11-07
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0.0297
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-06-30
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-3.0939
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-03-31
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-2.834
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2023-12-31
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.5108
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-09-30
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-8.7583
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-06-30
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-3.328
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-03-31
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0.1818
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2022-12-31
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
3.5462
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-09-30
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
2.5146
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-06-30
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
4.9269
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-03-31
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
7.6522
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2021-12-31
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
9.8815
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-09-30
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
6.5153
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-06-30
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
5.35
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
2.3575
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2020-12-31
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.5762
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
-0.5065
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-0.2785
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
-0.3194
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-12-31
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
-0.3356
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-09-30
Earnings History > 26 > report Date
2019-09-30
Earnings History > 26 > date
2019-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
-0.335
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-06-30
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
-0.3651
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2019-03-31
Earnings History > 28 > report Date
2019-03-31
Earnings History > 28 > date
2019-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
-0.3553
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AModerna expects 2025 revenue of $1.9B, above guidance Proactive financial news
Read more →Moderna reaffirms 2025-26 guidance, eyes multiple vaccine, oncology, and rare disease launches Proactive financial news
Read more →Showing 2 of 6
(Last Updated 2024-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Moderna, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-2.76
Date
2025-09-30
EPS Actual
-0.4389
EPS Estimate
-2.19
EPS Difference
1.7511
Surprise Percent
79.9589%
(Last Updated 2024-03-31)
(Last Updated 2024-03-31)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-03-31)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2024-03-31)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.